明德生物(002932.SZ)发布上半年业绩，归母净利润1249.73万元，同比下降80.82%

Group 1 - The core viewpoint of the article is that Mindray Bio (002932.SZ) reported a decline in both revenue and net profit for the first half of 2025, indicating financial challenges [1] - The company achieved operating revenue of 139 million yuan, a year-on-year decrease of 9.71% [1] - The net profit attributable to shareholders of the listed company was 12.4973 million yuan, reflecting a significant year-on-year decline of 80.82% [1] Group 2 - The net loss attributable to shareholders after deducting non-recurring gains and losses was 35.6218 million yuan, with a year-on-year loss increase of 23.59% [1] - The basic earnings per share were reported at 0.06 yuan [1]